| Literature DB >> 36094503 |
Mustapha Bouhrara1, Curtis Triebswetter1, Matthew Kiely1, Murat Bilgel2, Sudipto Dolui3, Guray Erus4, Osorio Meirelles5, Nick R Bryan6, John A Detre3,7, Lenore J Launer5.
Abstract
Importance: Decreased cerebral tissue integrity and cerebral blood flow (CBF) are features of neurodegenerative diseases. Brain tissue maintenance is an energy-demanding process, making it particularly sensitive to hypoperfusion. However, little is known about the association between blood flow and brain microstructural integrity, including in normative aging. Objective: To assess associations between CBF and changes in cerebral tissue integrity in white matter and gray matter brain regions. Design, Setting, and Participants: In this longitudinal cohort study, magnetic resonance imaging was performed on 732 healthy adults from the Coronary Artery Risk Development in Young Adults (CARDIA) study, a prospective longitudinal study (baseline age of 18-30 years) that examined participants up to 8 times during 30 years (1985-1986 to 2015-2016). Cerebral blood flow was measured at baseline (year 25 of the CARDIA study), and changes in diffusion tensor indices of fractional anisotropy (FA) and mean diffusivity (MD), measures of microstructural tissue integrity, were measured at both baseline and after approximately 5 years of follow-up (year 30). Analyses were conducted from November 5, 2020, to January 29, 2022. Main Outcomes and Measures: Automated algorithms and linear mixed-effects statistical models were used to evaluate the associations between CBF at baseline and changes in FA or MD.Entities:
Mesh:
Year: 2022 PMID: 36094503 PMCID: PMC9468885 DOI: 10.1001/jamanetworkopen.2022.31189
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Demographic Characteristics of the Participants
| Characteristic | Participants, No. (%) | |
|---|---|---|
| Year 25 (baseline) | Year 30 (follow-up) | |
| Total No. of participants | 654 | 433 |
| Sex | ||
| Male | 312 (47.7) | 203 (46.9) |
| Female | 342 (52.3) | 230 (53.1) |
| Cohort age, y | ||
| Mean (SD) | 50.3 (3.5) | 55.1 (3.5) |
| Range | 43-56 | 47-61 |
| Age, mean (SD), y | ||
| Women | 50.2 (3.4) | 55.2 (3.4) |
| Men | 50.4 (3.5) | 55.0 (3.5) |
| Race | ||
| Black | 247 (37.8) | 156 (36.0) |
| White | 394 (60.2) | 277 (64.0) |
Age did not differ significantly between men and women at baseline or follow-up. The full characterization of this study cohort is provided in Table 1 of Launer et al.[25]
Figure 1. Flowchart Showing Exclusion of Study Participants
Cohort demographic characteristics are shown in Table 1. CBF indicates cerebral blood flow; DTI, diffusion tensor imaging.
Regression Coefficient and Significance of the Regression Terms Incorporated in the Linear Mixed-Effects Model
| ROI | Age | Sex | Race | CBF | Time | Time × CBF | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β (SE), ×10−6 | β (SE), ×10−5 | β (SE), ×10−5 | β (SE), ×10−6 | β (SE), ×10−5 | β (SE), ×10−7 | |||||||
|
| ||||||||||||
| WB | ||||||||||||
| GM | 8.2 (1.9) | <.001 | −9.2 (1.4) | <.001 | 3.1 (1.4) | .052 | −0.4 (0.7) | .61 | 2.7 (0.1) | <.001 | −1.2 (1.4) | .45 |
| WM | 2.6 (1.2) | .04 | −1.2 (0.9) | .21 | 0.2 (0.9) | .92 | −0.7 (0.5) | .47 | 0.9 (0.1) | <.001 | −3.8 (1.1) | .002 |
| FL | ||||||||||||
| GM | 12.1 (2.7) | <.001 | −9.2 (2.0) | <.001 | 6.3 (1.9) | .005 | −0.9 (1.0) | .52 | 2.7 (0.1) | <.001 | −1.7 (1.5) | .41 |
| WM | 2.8 (1.4) | .06 | −0.9 (1.0) | .46 | 1.6 (1.0) | .20 | −1.1 (0.6) | .31 | 0.7 (0.1) | <.001 | −4.4 (1.3) | .002 |
| OL | ||||||||||||
| GM | 5.7 (2.1) | .014 | −10.7 (1.6) | <.001 | 0.4 (1.5) | .92 | −0.6 (0.8) | .55 | 2.9 (0.2) | <.001 | 0.0 (1.6) | .99 |
| WM | 2.0 (1.3) | .13 | −2.2 (1.0) | .03 | −2.3 (0.9) | .046 | −0.6 (0.5) | .47 | 0.3 (0.1) | .003 | −4.1 (1.1) | .002 |
| PL | ||||||||||||
| GM | 11.7 (3.1) | <.001 | −14.6 (2.2) | <.001 | 3.4 (2.2) | .20 | −1.3 (1.2) | .47 | 2.7 (0.2) | <.001 | 1.8 (1.7) | .42 |
| WM | 2.7 (1.6) | .12 | −2.7 (1.2) | .03 | −0.1 (1.2) | .93 | −1.5 (0.7) | .23 | 0.8 (0.1) | <.001 | −4.3 (1.5) | .002 |
| TL | ||||||||||||
| GM | 5.7 (1.6) | <.001 | −7.8 (1.1) | <.001 | 3.7 (1.1) | .005 | −0.6 (0.6) | .52 | 2.8 (0.1) | <.001 | −0.3 (1.5) | .91 |
| WM | 2.3 (1.1) | .04 | −0.2 (0.8) | .77 | −0.8 (0.8) | .47 | −0.5 (0.4) | .46 | 1.5 (0.1) | <.001 | −2.6 (0.9) | .01 |
|
| ||||||||||||
| WB | ||||||||||||
| GM | 8.2 (1.9) | <.001 | −9.2 (1.4) | <.001 | 3.1 (1.4) | .07 | −0.4 (0.7) | .87 | 2.7 (0.1) | <.001 | −1.2 (1.4) | .60 |
| WM | 2.6 (1.2) | .04 | −1.2 (0.9) | .21 | 0.2 (0.9) | .84 | −0.7 (0.5) | .43 | 0.9 (0.1) | <.001 | −3.8 (1.1) | .003 |
| FL | ||||||||||||
| GM | 12.3 (2.7) | <.001 | −9.6 (1.9) | <.001 | 6.5 (1.9) | .003 | −0.5 (0.9) | .87 | 2.7 (0.1) | <.001 | −0.6 (1.3) | .83 |
| WM | 2.2 (1.4) | .12 | −0.3 (1.0) | .77 | 1.5 (1.0) | .28 | −1.4 (0.5) | .008 | 0.7 (0.1) | <.001 | −6.3 (1.1) | <.001 |
| OL | ||||||||||||
| GM | 5.8 (2.1) | .01 | −10.6 (1.5) | <.001 | 0.3 (1.5) | .84 | −0.1 (0.7) | .92 | 2.9 (0.2) | <.001 | −2.7 (1.3) | .08 |
| WM | 2.5 (1.3) | .07 | −3.6 (0.9) | <.001 | −1.7 (1.0) | .19 | 0.4 (0.4) | .65 | 0.3 (0.1) | .002 | −0.1 (0.9) | .95 |
| PL | ||||||||||||
| GM | 10.8 (3.0) | <.001 | −11.7 (2.2) | <.001 | 1.9 (2.2) | .65 | −4.4 (1.0) | <.001 | 2.7 (0.2) | <.001 | −0.1 (1.4) | .95 |
| WM | 2.6 (1.6) | .11 | −2.1 (1.2) | .09 | −0.6 (1.2) | .75 | −2.4 (0.6) | <.001 | 0.8 (0.1) | <.001 | −2.0 (1.2) | .22 |
| TL | ||||||||||||
| GM | 5.8 (1.6) | <.001 | −8.2 (1.1) | <.001 | 3.9 (1.1) | .003 | −0.1 (0.6) | .92 | 2.8 (0.1) | <.001 | −0.8 (1.5) | .83 |
| WM | 2.5 (1.1) | .03 | −0.7 (0.8) | .40 | −0.6 (0.8) | .66 | 0.1 (0.4) | .92 | 1.5 (0.1) | <.001 | −2.6 (0.9) | .02 |
Abbreviations: CBF, cerebral blood flow; FL, frontal lobes; GM, gray matter; OL, occipital lobes; PL, parietal lobes; ROI, region of interest; TL, temporal lobes; WB, whole-brain; WM, white matter.
The mean diffusivity is the dependent variable. Regression coefficient and significance were determined after correction for false discovery rate. The linear mixed-effects model is given by the equation in the Methods.
Regression Coefficient and Significance of the Regression Terms Incorporated in the Linear Mixed-Effects Model
| ROI | Age | Sex | Race | CBF | Time | Time × CBF | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β (SE), ×10−4 | β (SE), ×10−3 | β (SE), ×10−3 | β (SE), ×10−4 | β (SE), ×10−3 | β (SE), ×10−5 | |||||||||
|
| ||||||||||||||
| WB | ||||||||||||||
| GM | −2.5 (1.3) | .16 | 3.3 (1.0) | .001 | −4.4 (0.9) | <.001 | −0.0 (0.5) | .98 | −2.0 (0.1) | <.001 | 2.3 (1.2) | .08 | ||
| WM | −2.9 (2.2) | .27 | −4.4 (1.6) | .008 | 4.8 (1.6) | .003 | 2.4 (0.9) | .03 | −0.5 (0.2) | .01 | 6.1 (2.0) | .009 | ||
| FL | ||||||||||||||
| GM | −2.6 (1.4) | .16 | 3.3 (1.0) | .003 | −4.6 (1.0) | <.001 | −0.4 (0.6) | .59 | −1.9 (0.1) | <.001 | 2.1 (1.2) | .10 | ||
| WM | −4.2 (2.4) | .16 | −5.1 (1.7) | .005 | 2.9 (1.7) | .08 | 2.9 (1.0) | .01 | −0.9 (0.2) | <.001 | 6.5 (1.9) | .007 | ||
| OL | ||||||||||||||
| GM | −1.6 (1.5) | .31 | 4.0 (1.1) | <.001 | −4.0 (1.1) | <.001 | 0.4 (0.6) | .58 | −2.4 (0.1) | <.001 | 0.6 (1.4) | .74 | ||
| WM | −3.1 (2.5) | .28 | 1.7 (1.8) | .34 | 5.6 (1.8) | .002 | 2.1 (1.0) | .10 | 0.4 (0.2) | .13 | 6.7 (2.4) | .01 | ||
| PL | ||||||||||||||
| GM | −3.9 (1.9) | .16 | 6.5 (1.4) | <.001 | −3.8 (1.4) | .006 | −0.8 (0.8) | .52 | −2.1 (0.1) | <.001 | 0.1 (1.5) | .97 | ||
| WM | −1.1 (2.8) | .70 | −7.4 (2.1) | <.001 | 7.4 (2.0) | <.001 | 4.4 (1.1) | <.001 | −0.2 (0.2) | .28 | 4.9 (2.1) | .04 | ||
| TL | ||||||||||||||
| GM | −2.5 (1.5) | .16 | 4.2 (1.1) | <.001 | −5.0 (1.1) | <.001 | 0.4 (0.6) | .59 | −2.1 (0.1) | <.001 | 1.2 (1.4) | .48 | ||
| WM | −3.7 (2.2) | .16 | −2.5 (1.6) | .13 | 5.9 (1.6) | <.001 | 1.4 (0.9) | .27 | −0.1 (0.2) | .53 | 6.1 (2.1) | .01 | ||
|
| ||||||||||||||
| WB | ||||||||||||||
| GM | −2.5 (1.3) | .14 | 3.3 (1.0) | .001 | −4.4 (0.9) | <.001 | −0.0 (0.5) | .98 | −2.0 (0.1) | <.001 | 2.3 (1.2) | .08 | ||
| WM | −2.9 (2.2) | .25 | −4.4 (1.6) | .007 | 4.8 (1.6) | .004 | 2.4 (0.9) | .03 | −0.5 (0.2) | .01 | 6.1 (2.0) | .004 | ||
| FL | ||||||||||||||
| GM | −2.6 (1.4) | .12 | 3.4 (1.0) | .001 | −4.7 (1.0) | <.001 | −0.8 (0.5) | .17 | −1.9 (0.1) | <.001 | 3.5 (1.0) | .002 | ||
| WM | −2.8 (2.3) | .21 | −6.4 (1.6) | <.001 | 3.3 (1.6) | .045 | 3.7 (0.8) | <.001 | −0.9 (0.2) | <.001 | 11.5 (1.6) | <.001 | ||
| OL | ||||||||||||||
| GM | −1.9 (1.5) | .25 | 5.4 (1.1) | <.001 | −4.8 (1.1) | <.001 | −1.2 (0.5) | .03 | −2.4 (0.1) | <.001 | 0.2 (1.0) | .88 | ||
| WM | −4.5 (2.5) | .14 | 5.8 (1.8) | .001 | 3.8 (1.8) | .04 | −0.3 (0.8) | .90 | 0.4 (0.2) | .14 | −7.3 (1.8) | <.001 | ||
| PL | ||||||||||||||
| GM | −3.6 (1.9) | .14 | 5.7 (1.4) | <.001 | −3.4 (1.4) | .02 | 0.2 (0.6) | .90 | −2.1 (0.1) | <.001 | 0.8 (1.3) | .59 | ||
| WM | −1.6 (2.8) | .57 | −6.8 (2.0) | .001 | 7.6 (2.0) | <.001 | 3.8 (0.9) | <.001 | −0.2 (0.2) | .27 | 1.3 (1.8) | .58 | ||
| TL | ||||||||||||||
| GM | −2.5 (1.5) | .17 | 4.1 (1.1) | <.001 | −4.9 (1.1) | <.001 | 0.7 (0.6) | .38 | −2.1 (0.1) | <.001 | 0.8 (1.4) | .59 | ||
| WM | −4.0 (2.2) | .13 | −1.7 (1.6) | .27 | 5.6 (1.6) | <.001 | 0.6 (0.9) | .72 | −0.1 (0.2) | .53 | 6.0 (2.1) | .009 | ||
Abbreviations: CBF, cerebral blood flow; FL, frontal lobes; GM, gray matter; OL, occipital lobes; PL, parietal lobes; ROI, region of interest; TL, temporal lobes; WB, whole-brain; WM, white matter.
Fractional anisotropy is the dependent variable. Regression coefficient and significance were determined after correction for false discovery rate. The linear mixed-effects model is given by the equation in the Methods.
Figure 2. Changes in Mean Diffusivity or Fractional Anisotropy as a Function of Time for 3 Different Values of Cerebral Blood Flow (CBF) Corresponding to the 20th, 50th, and 80th Percentile Values at Baseline
Examples are displayed for representative regions of interest. Lower baseline values of CBF flow are associated with steeper deteriorations in cerebral white matter (WM) and gray matter (GM) microstructures (ie, a steeper increase in mean diffusivity or a decrease in fractional anisotropy); this association is less pronounced for higher values of CBF at baseline.